Delivery Order SPE2DB25D3005-SPE2DB25FQEQF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,476.56 to AmerisourceBergen Drug Corp for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units. This contract represents a firm fixed-price delivery order with no set-aside designation, issued competitively on August 5, 2025, with an ultimate completion date of August 6, 2025. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $3,133.24 to AmerisourceBergen Drug Corp for Potassium Chloride Extended Release 10 MEQ tablets (500-count packaging). This was a competitively awarded, firm fixed-price delivery order with no set-aside designation, completed on April 24, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency awarded a $3,189.74 delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units, with completion scheduled for October 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Potassium Chloride Extended Release 8 MEQ tablets (500-count packages) with a ceiling value of $4,774.04. This is a firm fixed-price delivery order with an ultimate completion date of June 17, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $1,015.55 delivery order to AmerisourceBergen Drug Corp for Potassium Chloride Extended Release 20 MEQ tablets (100-count packaging) under a firm fixed price contract. The award, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a non-set-aside competitive procurement. Performance of this delivery order will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,691.84 to AmerisourceBergen Drug Corp for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by June 25, 2025. The pharmaceutical products will be supplied from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, supporting the federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,391.20 to AmerisourceBergen Drug Corp for Potassium Chloride Extended-Release 10 MEQ tablets in quantities of 1,000 units. This contract award, issued on June 24, 2025, with an ultimate completion date of June 25, 2025, represents a firm fixed price delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units, with a ceiling value of $5,993.44. This is a firm fixed price delivery order with an ultimate completion date of June 20, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $9,927.05 for the supply of Potassium Chloride Extended Release 8 MEQ tablets in quantities of 1,000 units. The award, issued on September 25, 2025, represents a firm fixed price delivery order with an ultimate completion date of September 26, 2025. This non-set-aside contract was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units, with a ceiling value of $1,611.86. This is a firm fixed-price delivery order with no set-aside designation, scheduled for completion by August 11, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB25D3005Indefinite Delivery Contract
- SPE2DB25D3005-SPE2DB25FQEQFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,474.28 to AmerisourceBergen Drug Corp for the supply of Potassium Chloride Extended Release 20 MEQ tablets in quantities of 100. This non-set-aside, firm fixed price delivery order was awarded on April 24, 2025, with an ultimate completion date of April 25, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999.99 million and extending through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen regularly fulfills competitively awarded delivery orders for the military and veteran healthcare systems through this prime contract vehicle. The company's extensive portfolio encompasses a broad range of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains, supporting the Defense Health Agency and other government healthcare customers worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 4/24/25 |